RxDoctor Payments Data

Stephanie Morris, APRN

Primary Care · Augusta, GANPI 1306311832

Payments from drug & device makers

$489in general payments, 2019–2025

Across 28 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$100
  • Novo Nordisk$51
  • Ferring Pharmaceuticals Inc.$48
  • Lilly USA, LLC$44
  • Boehringer Ingelheim$40
  • Merck$38
  • plus $168 from 8 others

What the payments were for

  • Food & beverage$489100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$489 in reported general payments places this provider in the 50th percentile of 235 primary care providers in Georgia.

See all primary care providers in Georgia

Medicare billing

Part B allowed, 2024
$363,182
Medicare patients
161
Services billed
4,833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban118$63,056
JardianceEmpagliflozin89$51,282
TrulicityDulaglutide42$45,378
MyrbetriqMirabegron65$27,814
FarxigaDapagliflozin Propanediol23$13,039
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,042
EntrestoSacubitril/Valsartan13$8,851
TradjentaLinagliptin14$6,626
Memantine Hcl196$6,354
Fluticasone-SalmeterolFluticasone Propion/Salmeterol39$6,022
Duloxetine Hcl167$5,496
Losartan Potassium308$5,030
Donepezil Hcl288$4,674
Colesevelam Hcl32$4,387
Potassium Chloride177$4,372

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$30$63,056118 claims
Boehringer IngelheimJardiance, Tradjenta$40$57,908103 claims
Lilly USA, LLCTrulicity$44$45,37842 claims
AstraZenecaFarxiga$100$13,03923 claims
GSKTrelegy Ellipta$11$11,04214 claims
NovartisEntresto$16$8,85113 claims
AbbVieCombigan$21$2,34111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 235 primary care providers in Georgia.

Other primary care in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →